Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

479 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of Glecaprevir/Pibrentasvir for Hepatitis C: Real-World Experience and Clinical Features of Retreatment Cases.
Sugiura A, Joshita S, Yamashita Y, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Nakano Y, Usuda S, Kiyosawa K, Tanaka E, Umemura T. Sugiura A, et al. Among authors: kiyosawa k. Biomedicines. 2020 Apr 3;8(4):74. doi: 10.3390/biomedicines8040074. Biomedicines. 2020. PMID: 32260271 Free PMC article.
Epidemiology and clinical aspects on hepatitis C.
Higuchi M, Tanaka E, Kiyosawa K. Higuchi M, et al. Among authors: kiyosawa k. Jpn J Infect Dis. 2002 Jun;55(3):69-77. Jpn J Infect Dis. 2002. PMID: 12195046 Review.
Epidemiology of hepatocellular carcinoma in Japan.
Umemura T, Kiyosawa K. Umemura T, et al. Among authors: kiyosawa k. Hepatol Res. 2007 Sep;37 Suppl 2:S95-S100. doi: 10.1111/j.1872-034X.2007.00169.x. Hepatol Res. 2007. PMID: 17877503
Epidemiology of hepatocellular carcinoma in Japan.
Umemura T, Ichijo T, Yoshizawa K, Tanaka E, Kiyosawa K. Umemura T, et al. Among authors: kiyosawa k. J Gastroenterol. 2009;44 Suppl 19:102-7. doi: 10.1007/s00535-008-2251-0. Epub 2009 Jan 16. J Gastroenterol. 2009. PMID: 19148802 Free article.
KIR3DL1-HLA-Bw4 combination and IL28B polymorphism predict response to Peg-IFN and ribavirin with and without telaprevir in chronic hepatitis C.
Umemura T, Ota M, Katsuyama Y, Wada S, Mori H, Maruyama A, Shibata S, Nozawa Y, Kimura T, Morita S, Joshita S, Komatsu M, Matsumoto A, Kamijo A, Kobayashi M, Takamatsu M, Yoshizawa K, Kiyosawa K, Tanaka E. Umemura T, et al. Among authors: kiyosawa k. Hum Immunol. 2014 Aug;75(8):822-6. doi: 10.1016/j.humimm.2014.06.003. Epub 2014 Jun 11. Hum Immunol. 2014. PMID: 24929144
Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E. Kimura T, et al. Among authors: kiyosawa k. Hepatol Res. 2017 Apr;47(5):405-418. doi: 10.1111/hepr.12762. Epub 2016 Jul 24. Hepatol Res. 2017. PMID: 27288988
Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals.
Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E. Sugiura A, et al. Among authors: kiyosawa k. J Viral Hepat. 2018 Dec;25(12):1462-1471. doi: 10.1111/jvh.12973. Epub 2018 Aug 30. J Viral Hepat. 2018. PMID: 30044517
[Hepatitis F virus].
Kiyosawa K, Tanaka E. Kiyosawa K, et al. Ryoikibetsu Shokogun Shirizu. 1995;(7):20-3. Ryoikibetsu Shokogun Shirizu. 1995. PMID: 8749402 Review. Japanese. No abstract available.
479 results